Pittsburgh pharmacist explains how medications can make people susceptible to heat-related illness
A pharmacist warns that certain medications may put people at greater risk of dehydration, heat exhaustion and heat stroke.
While people in the Pittsburgh area are trying to stay cool in the extreme heat, be aware that some medications don't mix well with hot weather.
"Heat, humidity, and sunlight are all factors that can impact medications and how a person responds to them," said Trisha Miller, a pharmacist at UPMC Presbyterian Shadyside.
She said it's important to know if your meds can put you at higher risk for heat-related illnesses. Medications that increase risk from heat include diuretics, beta blockers, anticholinergics, antidepressants, antipsychotics, antihistamines, antibiotics, antifungals and more.
"Some medications, like diuretics, these are frequently called water pills," Miller said. "They can lead to volume depletion or electrolyte imbalances and increase the risk of someone becoming dehydrated. Other medications, like certain antipsychotics or anti-seizure medications, can impair somebody's ability to sweat or regulate their body temperatures and lead to their body becoming overheated. And then there are certain types of antibiotics or acne medications that increase photosensitivity, which is when there's a sensitivity to sunlight or UV rays that can lead to sunburns."
Miller also said to never leave medications in hot places.
"Medications should never be stored or left in cars. Most medications, unless it specifically tells you different directions, should be stored at room temperature, protected from sunlight, and from humidity. .. We don't want to necessarily have them near windows that might get direct sunlight," she said.
But if you have to go out in the scorching heat, stay hydrated. Miller added to act quickly if you're feeling off.
"That can be lightheadedness, that can be dizziness, that can be short of breath, headaches. I think catching those signs early and reaching out to their providers to make sure that things don't escalate because things can escalate very quickly in heat," Miller said.
If you don't know how your medications react to heat or how to store them, just ask your pharmacist.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Dietitian Who Lost 60 Pounds With GLP-1 Drug Reveals Foods to Avoid and Prioritize
Jennifer Lynn-Pullman is a certified specialist in obesity and weight management, so she was frustrated when her own weight kept rising over the years. 'I had struggled with my weight for a long time. My whole family struggles as well, so it's very genetic,' Lynn-Pullman, 48, a registered dietitian and manager of clinical dietetics for Vida Health, tells "And of course, in your 40s with perimenopause, it doesn't get any easier.' Lynn-Pullman, who lives in suburban Philadelphia, was alarmed when her cholesterol went up for the first time two years ago and her A1C — a measure of blood sugar — was trending up. At 5 feet, 6 inches tall, she weighed 200 pounds and worried she was on track to develop Type 2 diabetes in her 50s like her parents. Her doctor prescribed Wegovy, the version of Ozempic approved for weight loss. It's part of the GLP-1 class of medications that mimic a hormone the body produces after eating to decrease appetite and help the body manage insulin production. After starting the drug in 2023, Lynn-Pullman lost 60 pounds in 10 months and has maintained that weight for more than a year. Like many patients, she experienced side effects and had to figure out which foods to avoid on a GLP-1 and how to prevent muscle loss. Here are her tips for eating on a GLP-1 based on her own experience: Lynn-Pullman had side effects for the first six months, usually when her medication dosage was increased. GLP-1 drugs slow stomach emptying, one of the reasons patients can experience uncomfortable symptoms. Nausea and vomiting are some of the most common side effects. For nausea, Lynn-Pullman prefers to use ginger gum. She also prepares easy to digest foods like a smoothie, soup and crackers that aren't too heavy for her stomach. Vomiting is usually due to eating too much or consuming high-fat foods, so she advises eating smaller meals, not eating too fast and avoiding greasy foods. 'Fat just stays in your stomach longer,' she says. 'With someone whose stomach is emptying much slower, it causes more of an upset.' Lynn-Pullman realized her vomiting episodes were caused by high-fiber muffins she was eating to help ease constipation. Once she cut them out, the problem stopped. The dietitian decided to treat herself like her bariatric surgery patients. 'I realized that because Wegovy causes such an increased level of satiety and such a long level of fullness, that it was very similar to those patients,' she says. Lynn-Pullman eats very small frequent meals she sometimes calls 'eating episodes.' She eats a higher-protein diet to help combat any muscle loss. She has protein every time she eats, consuming that food first, then fruits and vegetables. Any starchy food is last, if there's even room for it. Since liquid fills up the stomach, she suggests not drinking beverages with meals to get enough food in, then hydrating between meals. Here's her typical daily menu: Breakfast: A protein shake, cereal with fiber and ultrafiltered milk, which contains more protein than regular milk. Lunch: A turkey sandwich or salad topped with chicken. Dinner: Chicken or salmon with a vegetable. She occasionally eats rice or pasta on the side, but it fills her up too much, so she usually skips it. Snacks: An apple with peanut butter or nuts with a piece of fruit. Lynn-Pullman always loved sweets, noting she couldn't pass up a cookie or a piece of chocolate, especially in the afternoon. But after she began using Wegovy, she stopped craving sugar. 'It was the most miraculous thing,' Lynn-Pullman recalls. 'The food noise, that inner voice saying, 'Go get something sweet' — it vanished.' Today, she occasionally eats dark chocolate or might split a dessert with her husband if she goes out to dinner, but mostly skips sweets. When it comes to alcohol, she has a drink 'once in a blue moon if she goes to a party." 'The thing that I worry about is being nauseous or even feeling dehydrated the next day,' Lynn-Pullman says. 'We usually suggest that patients refrain from it just because of all of those potential side effects.' The dietitian works out three times a week, focusing on weight training to minimize muscle loss. Three months after starting Wegovy, Lynn-Pullman noticed she was cold all the time, even in the August summer heat. She began journaling her food intake and discovered she was eating only 800 calories a day, with very little protein. 'It's easy to do on a GLP-1 because you don't feel hungry and you fill up quickly,' Lynn-Pullman says. 'We worry about malnutrition, we worry about people not getting enough nutrients.' When she started eating more protein and calories, her symptoms went away quickly. That's why it's important to work with a dietitian and report symptoms like feeling cold, tired or exhausted, or noticing hair loss — potential symptoms of eating too little, Lynn-Pullman notes. This article was originally published on
Yahoo
33 minutes ago
- Yahoo
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
The healthcare sector offers an abundance of high-growth investment opportunities. Companies leveraging artificial intelligence and genomic medicine are delivering innovative therapies with significant potential. Small-cap and under-the-radar stocks with strong growth possibilities merit closer investor attention. 10 stocks we like better than TransMedics Group › There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving. Investors stand to benefit as healthcare leaders and emerging players address the needs of an aging global population and the rising prevalence of chronic diseases. Here are 10 under-the-radar healthcare stocks that could be great buys for your portfolio. Certara (NASDAQ: CERT) is poised to capitalize on the transformation in medicine driven by artificial intelligence (AI), providing bio-simulation software and services that accelerate drug development. The company plays a crucial role in the pharmaceutical industry. Over 90% of all novel drugs approved by the Food and Drug Administration (FDA) since 2014 have leveraged its technology. Its AI-driven solutions enhance research and development (R&D), enabling faster and more precise drug development. Certara deserves a closer look by investors seeking to tap into the AI-driven healthcare transformation. Beam Therapeutics (NASDAQ: BEAM) is a clinical-stage biotech pioneering precision-based gene editing therapies for genetic diseases, including sickle cell disease. Its innovative technology enables precise single-nucleotide DNA changes, potentially offering a safer alternative to traditional CRISPR genetic engineering. Beam has reported early success in gene correction, with its lead candidate, BEAM-101, in phase 1/2 trials for sickle cell disease. While the company still has a lot to prove, its differentiated approach and clinical progress position it for remarkable growth in the long term. Inspire Medical Systems (NYSE: INSP) develops implantable neurostimulation devices for obstructive sleep apnea, offering its FDA-approved Inspire therapy as a noninvasive alternative to CPAP machines. In its first quarter (the period ended March 31), revenue surged 23% year over year to $201 million, driven by growing U.S. adoption and new international approvals. With increasing demand for sleep apnea treatment, Inspire has a significant opportunity to capture market share. Insulet (NASDAQ: PODD) specializes in tubeless insulin pump technology. Its Omnipod system simplifies diabetes management for Type 1 and insulin-dependent Type 2 patients globally, offering convenience and improved outcomes. With a 2025 revenue growth target of 19% to 22%, the company is poised for continued expansion, particularly in underpenetrated international markets. Insulet's strong growth trajectory positions it to reward shareholders further. Krystal Biotech (NASDAQ: KRYS) focuses on rare skin diseases. Its FDA-approved gene therapy, Vyjuvek, for dystrophic epidermolysis bullosa (fragile skin that blisters easily) is expected to approach $400 million in revenue this year, solidifying its position as a best-in-class treatment. Vyjuvek's success validates Krystal's R&D, bolstering confidence in its pipeline and unlocking added market potential. LifeMD (NASDAQ: LFMD) operates a telehealth platform providing specialized virtual care in weight loss, men's health, and dermatology. A partnership with Novo Nordisk to offer Wegovy, a leading GLP-1 treatment, has driven impressive growth, with first-quarter revenue surging 49% year over year for the period ended March 31. LifeMD could expand its growing user base into a comprehensive health management ecosystem to fuel growth and solidify its telehealth leadership. Option Care Health (NASDAQ: OPCH) is the leading U.S. provider of home and alternative-site infusion services, delivering crucial therapies for chronic and acute conditions like cancer, immune deficiencies, and infections. As the healthcare industry shifts toward more personalized and cost-effective care, Option Care Health is in position to capitalize on the strong demand, with its extensive network and high-quality services. Tempus AI (NASDAQ: TEM) harnesses artificial intelligence to advance precision medicine, using its collection of clinical and molecular data from more than 40 million patients to power diagnostics in oncology, cardiology, and beyond. The company projects its revenue to climb by more than 80% this year, to about $1.3 billion. Tempus AI's scalable platform and extensive data ecosystem present substantial opportunities for expansion and impact in personalized healthcare. TransMedics Group (NASDAQ: TMDX) has revolutionized organ transplantation with its Organ Care System (OCS), the only FDA-approved device for heart, lung, and liver transplants that extends organ preservation time. The company's projected revenue growth of 30% this year underscores the strong momentum in a global expansion opportunity. Veeva Systems (NYSE: VEEV) offers cloud-based software that streamlines clinical, regulatory, and commercial processes for life sciences companies. Serving over 1,000 customers, including major pharmaceutical companies and emerging biotechs, Veeva's platform is well positioned to capitalize on the industry's increasing reliance on digital solutions for innovation and compliance. Before you buy stock in TransMedics Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and TransMedics Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Dan Victor has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Beam Therapeutics, Inspire Medical Systems, TransMedics Group, and Veeva Systems. The Motley Fool recommends Insulet, Krystal Biotech, and Novo Nordisk. The Motley Fool has a disclosure policy. 10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential was originally published by The Motley Fool
Yahoo
41 minutes ago
- Yahoo
Carrie Johnson admitted to hospital amid ‘brutal' week
Carrie Johnson, the wife of Boris Johnson, has been hospitalised with severe dehydration just weeks after giving birth. The incident prompted a stark warning from Ms Johnson about the critical importance of proper food and fluid intake for new mothers. The 37-year-old welcomed Poppy Eliza Josephine Johnson – her fourth child with the former prime minister – on 21 May. She revealed her two-night hospital stay on an Instagram story. Sharing a photo of herself cradling her newborn in hospital, she remarked that the experience was "not on my postpartum bingo card". Ms Johnson's personal ordeal comes as Britain prepares for another heatwave this weekend, with temperatures expected to exceed 30C and an amber heat health alert already in place. She wrote: 'Being hospitalised for two nights for severe dehydration was not on my postpartum bingo card.' She urged breastfeeding mothers to make sure they eat and drink enough, 'especially if your babe is clusterfeeding'. Advice on the NHS website tells new mothers to drink plenty of fluids and to have a drink beside them as the settle down to breastfeed. Water, lower fat milks, lower sugar or sugar-free drinks are all good choices, according to the NHS. Ms Johnson thanked everyone who has helped them get through a 'brutal' week. With an Amber Heat Health alert declared for the East Midlands, South East, South West, East of England and London, it's worth watching out for those who might find it difficult to cope with high temperatures. ☀️ 🌡️ Check our blog post for handy tips: — UK Health Security Agency (@UKHSA) June 27, 2025 She wrote: 'This week has honestly been brutal. 'Mastitis (me), reflux (her), dehydration (me). What a pair we are! 'But thank you for all the kind messages, especially all the brilliant advice on reflux. Really appreciate it and made me feel way less alone going thru it all. 'And as ever, thanks to our amazing NHS.' The amber heat health alert, which covers London, the East Midlands, South East, South West and East of England, came into force on Friday and will last until 6pm on Tuesday. The UK Health Security Agency (UKHSA) has also issued a yellow alert for Yorkshire and Humber and the West Midlands for the same time period, with the agency warning of significant impacts across health and social care services. The heatwave is also affecting broad parts of mainland Europe, and a Dutch tourist died of heatstroke in Mallorca, according to local reports. The 34-year-old collapsed while hiking with friends in Camí de Son Sales, the Majorca Daily Bulletin reported. Emergency services attempted to resuscitate him but were unable to, according to the publication.
